Clinical trial results Sarcoidosis-associated small fiber neuropathy: In a blinded, placebo-controlled trial, 28 days of daily subcutaneous ARA-290 administration in patients with documented small nerve fiber loss produced significant improvements
Eric Favre - 1 bottle of 500 milliliters in Apple / Kiwi or Tropical flavor
It sounds like it is worth pursuing a larger trial, but these results cannot demonstrate that liraglutide can protect against dementia." The ongoing phase 3 EVOKE trial is investigating the effects of the GLP-1 receptor agonist semaglutide in early AD
From liver detox to radiant skin, its benefits are real but only if you take it right
doi: 10.1164/rccm.201502-0387OC Summary Keywords aging, Nrf2, pulmonary Mycobacterium avium complex (MAC) disease, RNA-seq, secretory leukocyte protease inhibitor (SLPI) Citation Matsumura S, Matsuyama M, Nakajima M, Sakai C, Ueda K, Nonaka M, Nishino K, Wei Z, Yabuuchi Y, Kuramoto K, Yazaki K, Yoshida K, Kiwamoto T, Morishima Y, Ishii Y, Muratani M and Hizawa N (2026) The Nrf2-SLPI axis in aging and its role in the pathophysiology of pulmonary Mycobacterium avium complex disease
Its vegan capsule makes it a convenient choice for a variety of dietary preferences.